| 11642310 |
Posterior segment drug delivery |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, Hanson S. Gifford, III, K. Angela Macfarlane +5 more |
2023-05-09 |
|
| 11065151 |
Therapeutic agent formulations for implanted devices |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, K. Angela Macfarlane, Cary J. Reich +3 more |
2021-07-20 |
|
| 10874548 |
Therapeutic agent formulations for implanted devices |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, K. Angela Macfarlane, Cary J. Reich +3 more |
2020-12-29 |
|
| 10656152 |
Posterior segment drug delivery |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, Hanson S. Gifford, III, K. Angela Macfarlane +5 more |
2020-05-19 |
|
| 8808727 |
Posterior segment drug delivery |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, Hanson S. Giffor, III, K. Angela Macfarlane +5 more |
2014-08-19 |
|
| 8535681 |
Sustained drug delivery system |
Kathleen Cogan Farinas |
2013-09-17 |
|
| 8530189 |
Sustained drug delivery system |
Kathleen Cogan Farinas |
2013-09-10 |
|
| 8399006 |
Posterior segment drug delivery |
Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, Hanson S. Gifford, III, K. Angela Macfarlane +5 more |
2013-03-19 |
|
| 6582928 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
2003-06-24 |
$271,790,000 |
| 6124435 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
2000-09-26 |
$772,268,000 |
| 5929211 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
1999-07-27 |
$39,085,000 |
| 5889155 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
1999-03-30 |
$14,085,000 |
| 5851989 |
Method of extending the plasma half-life of vascular endothelial cell growth factor |
Nishit Modi, Ralph Schwall, Thomas Zioncheck |
1998-12-22 |
$6,623,000 |
| 5849689 |
Method of extending the plasma half-life of deletion variants of hepatocyte growth factor |
Nishit Modi, Ralph Schwall, Thomas Zioncheck |
1998-12-15 |
$3,161,000 |
| 5605791 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
1997-02-25 |
$3,259,000 |
| 5464815 |
Inhibition of heparin-binding |
Nishit Modi, Ralph Schwall, Thomas Zioncheck |
1995-11-07 |
$7,586,000 |
| 5329028 |
Carbohydrate-directed cross-linking reagents |
Avi Ashkenazi, Timothy Kogan |
1994-07-12 |
$4,353,000 |
